Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia

British Journal of Haematology

Volumn 171, Issue 5, 2015, Pages 671-682

  Curtis, Brian R ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

Fetal and neonatal alloimmune thrombocytopenia pathogenesis; Human platelet antigens; Neonatal alloimmune thrombocytopenia; Platelet antibody; Prophylaxis

Indexed keywords

HLA DR ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PLACEBO; RHESUS D ANTIBODY; THROMBOCYTE ANTIGEN;

ALLOIMMUNIZATION; ANTIGEN EXPRESSION; ARTICLE; FETOPLACENTAL UNIT; FETUS; FETUS CELL; FUCOSYLATION; HUMAN; IMMUNE RESPONSE; INFECTION; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PATHOGENESIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN TRANSPORT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE FUNCTION; ANIMAL; ANTIGEN ANTIBODY REACTION; CELLULAR IMMUNITY; DISEASE MODEL; FEMALE; FETAL DISEASES; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; MATERNAL EXPOSURE; MOUSE; PHYSIOLOGY; PREGNANCY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

ANIMALS; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, HUMAN PLATELET; DISEASE MODELS, ANIMAL; FEMALE; FETAL DISEASES; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INFANT, NEWBORN; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MICE; PLACENTAL CIRCULATION; PREGNANCY; RHO(D) IMMUNE GLOBULIN; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84955369477     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13639     Document Type: Article

References (111)

1. Alberry, M., Maddocks, D., Jones, M., Abdel Hadi, M., Abdel-Fattah, S., Avent, N. & Soothill, P.W. (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenatal Diagnosis, 27, 415-418.
2. Allaby, M., Lines, C. & Pittam, G. (2012) Screening for fetomaternal alloimmune thrombocytopenia: a report for the UK National Screening Committee. Available at: http://legacy.screening.nhs.uk/thrombocytopenia. [Accessed July 9, 2015]
3. Bakchoul, T., Boylan, B., Sachs, U.J., Bein, G., Ruan, C., Santoso, S. & Newman, P.J. (2009) Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion, 49, 265-270.
4. Bakchoul, T., Kubiak, S., Krautwurst, A., Roderfeld, M., Siebert, H.C., Bein, G., Sachs, U.J. & Santoso, S. (2011) Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion, 51, 2455-2461.
5. Bakovíc, M.P., Selman, M.H.J., Hoffmann, M., Rudan, I., Campbell, H., Deelder, A.M., Lauc, G. & Wuhrer, M. (2013) High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. Journal of Proteome Research, 12, 821-831.
6. Berkowitz, R.L., Bussel, J.B. & McFarland, J.G. (2006) Alloimmune thrombocytopenia: state of the art 2006. American Journal of Obstetrics and Gynecology, 195, 907-913.
7. Bertrand, G. & Kaplan-Gouet, C. (2011) Human platelet antigen genotyping and diagnosis of antiplatelet alloimmunization. In: BeadChip Molecular Immunohematology (ed. by P.M. Ness, S.R. Solan & J.M. Moulds ), pp. 73-81. Springer, New York.
8. Bianchi, D.W. (2004) Circulating fetal DNA: its origin and diagnostic potential-a review. Placenta, 25(Suppl. A), S93-S101.
9. Bianchi, D.W. & Wilkins-Haug, L. (2013) Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clinical Chemistry, 60, 78-87.
10. Bianchi, D.W., Zickwolf, G.K., Weil, G.J., Sylvester, S. & DeMaria, M.A. (1996) Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proceedings of the National Academy of Sciences of the United States of America, 93, 705-708.
11. Bianchi, D.W., Van Mieghem, T., Shaffer, L.G., Faas, B.H., Chitty, L.S., Ghidini, A. & Deprest, J. (2014) In case you missed it: the Prenatal Diagnosis section editors bring you the most significant advances of 2013. Prenatal Diagnosis, 34, 1-5.
12. Bowman, J. (2003) Thirty-five years of Rh prophylaxis. Transfusion, 43, 1661-1666.
13. Bussel, J.B. & Primiani, A. (2008) Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Reviews, 22, 33-52.
14. Bussel, J.B., Berkowitz, R.L., Lynch, L., Lesser, M.L., Paidas, M.J., Huang, C.L. & McFarland, J.G. (1996) Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. American Journal of Obstetrics and Gynecology, 174, 1414-1423.
15. Bussel, J.B., Berkowitz, R.L. & McFarland, J.G. (1997) Maternal IVIG in neonatal alloimmune thrombocytopenia. British Journal of Haematology, 98, 493-494.
16. Bussel, J.B., Zacharoulis, S., Kramer, K., McFarland, J.G., Pauliny, J. & Kaplan, C. (2005) Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatric Blood & Cancer, 45, 176-183.
17. Chen, P., Li, C., Lang, S., Zhu, G., Reheman, A., Spring, C.M., Freedman, J. & Ni, H. (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood, 116, 3660-3668.
18. Covas, D.T., Biscaro, T.A., Nasciutti, D.C., Guerreiro, J.F., Santos, S.E. & Zago, M.A. (2000) Gene frequencies of the HPA-3 and HPA-5 platelet antigen alleles among the Amerindians. European Journal of Haematology, 65, 128-131.
19. Crow, A.R. & Lazarus, A.H. (2008) The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know? Transfusion Medicine Reviews, 22, 103-116.
20. Curtis, B.R. (2008) Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Seminars in Thrombosis and Hemostasis, 34, 539-548.
21. Curtis, B. & McFarland, J. (2009) Detection and identification of platelet antibodies and antigens in the clinical laboratory. Immunohematology, 25, 125-135.
22. Curtis, B.R. & McFarland, J.G. (2013) Human platelet antigens - 2013. Vox Sanguinis, 106, 93-102.
23. Curtis, B.R., Ali, S., Glazier, A.M., Ebert, D.D., Aitman, T.J. & Aster, R.H. (2002) Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion, 42, 1173-1179.
24. Davoren, A., Curtis, B.R., Aster, R.H. & McFarland, J.G. (2004) Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion, 44, 1220-1225.
25. Dawe, G.S., Tan, X.W. & Xiao, Z.C. (2007) Cell migration from baby to mother. Cell Adhesion and Migration, 1, 19-27.
26. Decary, F., L'Abbe, D., Tremblay, L. & Chartrand, P. (1991) The immune response to the HPA-1a antigen: association with HLA-DRw52a. Transfusion Medicine (Oxford, England), 1, 55-62.
27. Denomme, G.A. & Van Oene, M. (2005) High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion, 45, 660-666.
28. Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I. & Tchernia, G. (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood, 89, 4402-4406.
29. Durand-Zaleski, I., Schlegel, N., Blum-Boisgard, C., Uzan, S., Dreyfus, M. & Kaplan, C. (1996) Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Immune Thrombocytopenia Working Group. American Journal of Perinatology, 13, 423-431.
30. Eksteen, M., Tiller, H., Averina, M., Heide, G., Kjaer, M., Ghevaert, C., Michaelsen, T.E., Ihle, O., Husebekk, A., Skogen, B. & Stuge, T.B. (2015) Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy. Journal of Immunology, 194, 5751-5760.
31. Espinoza, J.P., Caradeux, J., Norwitz, E.R. & Illanes, S.E. (2013) Fetal and neonatal alloimmune thrombocytopenia. Reviews in Obstetrics & Gynecology, 6, e15-e21.
32. Flug, F., Karpatkin, M. & Karpatkin, S. (1994) Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? British Journal of Haematology, 86, 1-5.
33. Fontao-Wendel, R., Bertrand, G., Chong, W., Sachs, U., Kaplan, C., Tsuno, N. & Santoso, S. (2014) Report on the 16th international society of blood transfusion platelet immunology workshop. ISBT Science Series. Vox Sang, 9, 295-303.
34. Gafni, A. & Blanchette, V.S. (1988) Screening for neonatal alloimmune thrombocytopenia: an economic perspective. Curr Stud Hematol Blood Transfus, 54, 140-147.
35. Garner, S.F., Smethurst, P.A., Merieux, Y., Aeby, C., Smith, G., Armour, K.L., Scott, M.L., Williamson, L.M., Metcalfe, P., Goodall, A.H., Clark, M.R., Rigal, D., Schawaller, M. & Ouwehand, W.H. (2000) A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a. British Journal of Haematology, 108, 440-447.
36. Ghevaert, C., Wilcox, D.A., Fang, J., Armour, K.L., Clark, M.R., Ouwehand, W.H. & Williamson, L.M. (2008) Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. Journal of Clinical Investigation, 118, 2929-2938.
37. Ghevaert, C., Herbert, N., Hawkins, L., Grehan, N., Cookson, P., Garner, S.F., Crisp-Hihn, A., Lloyd-Evans, P., Evans, A., Balan, K., Ouwehand, W.H., Armour, K.L., Clark, M.R. & Williamson, L.M. (2013) Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers. Blood, 122, 313-320.
38. Goldman, M., Decary, F. & David, M. (1994) Should all pregnant women be tested for their platelet PLA (Zw, HPA-1) phenotype? British Journal of Haematology, 87, 670.
39. Gruel, Y., Boizard, B., Daffos, F., Forestier, F., Caen, J. & Wautier, J.L. (1986) Determination of platelet antigens and glycoproteins in the human fetus. Blood, 68, 488-492.
40. Gunnink, S.F., Vlug, R., Fijnvandraat, K., van der Bom, J.G., Stanworth, S.J. & Lopriore, E. (2014) Neonatal thrombocytopenia: etiology, management and outcome. Expert Review of Hematology, 7, 387-395.
41. Harrington, W.J., Sprague, C.C., Minnich, V., Moore, C.V., Aulvin, R.C. & Dubach, R. (1953) Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Annals of Internal Medicine, 38, 433-469.
42. Herzenberg, L.A., Bianchi, D.W., Schroder, J., Cann, H.M. & Iverson, G.M. (1979) Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proceedings of the National Academy of Sciences of the United States of America, 76, 1453-1455.
43. Hickstein, H., Barz, D., Kulz, T., Korten, G., Muller, H. & Schmidt, R. (2002) Protein A immunoadsorption in a pregnant woman with habitual abortion. Transfusion and Apheresis Science, 27, 259-261.
44. Hong, F., Ruiz, R., Price, H., Griffiths, A., Malinoski, F. & Woloski, M. (1998) Safety profile of WinRho anti-D. Seminars in Hematology, 35, 9-13.
45. Huppertz, B., Kingdom, J., Caniggia, I., Desoye, G., Black, S., Korr, H. & Kaufmann, P. (2003) Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta, 24, 181-190.
46. Hurd, C.M., Cavanagh, G., Schuh, A., Ouwehand, W.H. & Metcalfe, P. (2002) Genotyping for platelet-specific antigens: techniques for the detection of single nucleotide polymorphisms. Vox Sanguinis, 83, 1-12.
47. Jackson, D.J., Eastlake, J.L. & Kumpel, B.M. (2014) Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model. Clinical and Experimental Immunology, 176, 23-36.
48. Jefferis, R. (2005) Glycosylation of natural and recombinant antibody molecules. Advances in Experimental Medicine and Biology, 564, 143-148.
49. Jin, J.C., Ferd, P., Lakkaraja, M., Manotas, K., Vinograd, C., Gabor, J., Selegean, J., Wissert, M., Berkowitz, R.L., McFarland, J.G. & Bussel, J.B. (2014) Necessity of therapeutic prophylaxis in fetal/neonatal alloimmune thrombocytopenia antenatally in first pregnancies. American Journal of Hematology, 89, E17.
50. Kaplan, C., Morel-Kopp, M.C., Kroll, H., Kiefel, V., Schlegel, N., Chesnel, N. & Mueller-Eckhardt, C. (1991) HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. British Journal of Haematology, 78, 425-429.
51. Kapur, R., Kustiawan, I., Vestrheim, A., Koeleman, C.A., Visser, R., Einarsdottir, H.K., Porcelijn, L., Jackson, D., Kumpel, B., Deelder, A.M., Blank, D., Skogen, B., Killie, M.K., Michaelsen, T.E., de Haas, M., Rispens, T., van der Schoot, C.E., Wuhrer, M. & Vidarsson, G. (2014) A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood, 123, 471-480.
52. Khosrotehrani, K. & Bianchi, D.W. (2005) Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. Journal of Cell Science, 118, 1559-1563.
53. Killie, M.K., Kjeldsen-Kragh, J., Randen, I., Skogen, B. & Husebekk, A. (2004) Evaluation of a new flow cytometric HPA 1a screening method. A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women. Transfusion and Apheresis Science, 30, 89-92.
54. Killie, M.K., Kjeldsen-Kragh, J., Husebekk, A., Skogen, B., Olsen, J.A. & Kristiansen, I.S. (2007) Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia. BJOG, 114, 588-595.
55. Killie, M.K., Husebekk, A., Kjeldsen-Kragh, J. & Skogen, B. (2008) A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica, 93, 870-877.
56. Kjeldsen-Kragh, J. & Skogen, B. (2013) Mechanisms and prevention of alloimmunization in pregnancy. Obstetrical & Gynecological Survey, 68, 526-532.
57. Kjeldsen-Kragh, J., Killie, M.K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Oian, P., Dahl, L.B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Gronn, M., Skogen, B. & Husebekk, A. (2007) A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood, 110, 833-839.
58. Kjeldsen-Kragh, J., Ni, H. & Skogen, B. (2012) Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Current Opinion in Hematology, 19, 469-474.
59. Knight, M., Pierce, M., Allen, D., Kurinczuk, J.J., Spark, P., Roberts, D.J. & Murphy, M.F. (2011) The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources. British Journal of Haematology, 152, 460-468.
60. Kumpel, B.M. & Elson, C.J. (2001) Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends in Immunology, 22, 26-31.
61. Kumpel, B.M. & Manoussaka, M.S. (2011) Placental immunology and maternal alloimmune responses. Vox Sanguinis, 102, 2-12.
62. Kumpel, B.M. & Manoussaka, M.S. (2012) Placental immunology and maternal alloimmune responses. Vox Sanguinis, 102, 2-12.
63. Kumpel, B.M., Sibley, K., Jackson, D.J., White, G. & Soothill, P.W. (2008) Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy. Transfusion, 48, 2077-2086.
64. Kuo, T.T., Baker, K., Yoshida, M., Qiao, S.W., Aveson, V.G., Lencer, W.I. & Blumberg, R.S. (2010) Neonatal Fc receptor: from immunity to therapeutics. Journal of Clinical Immunology, 30, 777-789.
65. Larche, M. & Wraith, D.C. (2005) Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nature Medicine, 11, S69-S76.
66. Le Toriellec, E., Chenet, C. & Kaplan, C. (2012) Safe fetal platelet genotyping: new developments. Transfusion, 53, 1755-1762.
67. Li, C., Piran, S., Chen, P., Lang, S., Zarpellon, A., Jin, J.W., Zhu, G., Reheman, A., van der Wal, D.E., Simpson, E.K., Ni, R., Gross, P.L., Ware, J., Ruggeri, Z.M., Freedman, J. & Ni, H. (2011) The maternal immune response to fetal platelet GPIbalpha causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. Journal of Clinical Investigation, 121, 4537-4547.
68. Li, C., Chen, P., Vadasz, B., Ma, L., Zhou, H., Lang, S., Freedman, J. & Ni, H. (2013) Co-stimulation with LPS or Poly I: C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia. Thrombosis and Haemostasis, 110, 1250-1258.
69. Lo, Y.M., Patel, P., Wainscoat, J.S., Sampietro, M., Gillmer, M.D. & Fleming, K.A. (1989) Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet, 2, 1363-1365.
70. Lo, Y.M., Corbetta, N., Chamberlain, P.F., Rai, V., Sargent, I.L., Redman, C.W. & Wainscoat, J.S. (1997) Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485-487.
71. Lo, E.S., Lo, Y.M., Hjelm, N.M. & Thilaganathan, B. (1998) Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy. British Journal of Haematology, 100, 605-606.
72. Loewenthal, R., Rosenberg, N., Kalt, R., Dardik, R., Landau, M., Yahalom, V., Avishai, O., Frenkel, O., Gazit, E., Steinberg, D.M., Lipitz, S. & Salomon, O. (2013) Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia. Transfusion, 53, 344-352.
73. Maslanka, K., Yassai, M. & Gorski, J. (1996) Molecular identification of T cells that respond in a primary bulk culture to a peptide derived from a platelet glycoprotein implicated in neonatal alloimmune thrombocytopenia. Journal of Clinical Investigation, 98, 1802-1808.
74. McQuilten, Z.K., Wood, E.M., Savoia, H. & Cole, S. (2011) A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51, 191-198.
75. Medzhitov, R. (2008) Origin and physiological roles of inflammation. Nature, 454, 428-435.
76. Moldaver, D. & Larche, M. (2011) Immunotherapy with peptides. Allergy, 66, 784-791.
77. Mueller-Eckhardt, C., Kiefel, V., Grubert, A., Kroll, H., Weisheit, M., Schmidt, S., Mueller-Eckhardt, G. & Santoso, S. (1989a) 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet, 1, 363-366.
78. Mueller-Eckhardt, C., Kiefel, V., Kroll, H. & Mueller-Eckhardt, G. (1989b) HLA-DRw6, a new immune response marker for immunization against the platelet alloantigen Bra. Vox Sanguinis, 57, 90-91.
79. Murphy, M.F. & Bussel, J.B. (2007) Advances in the management of alloimmune thrombocytopenia. British Journal of Haematology, 136, 366-378.
80. Murphy, M.F. & Williamson, L.M. (2000) Antenatal screening for fetomaternal alloimmune thrombocytopenia: an evaluation using the criteria of the UK National Screening Committee. British Journal of Haematology, 111, 726-732.
81. Murphy, M.F., Williamson, L.M. & Urbaniak, S.J. (2002) Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sanguinis, 83, 409-416.
82. Newman, P.J., Derbes, R.S. & Aster, R.H. (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. Journal of Clinical Investigation, 83, 1778-1781.
83. Ni, H., Chen, P., Spring, C.M., Sayeh, E., Semple, J.W., Lazarus, A.H., Hynes, R.O. & Freedman, J. (2006) A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy. Blood, 107, 2976-2983.
84. Ohto, H., Miura, S., Ariga, H., Ishii, T., Fujimori, K. & Morita, S. (2004) The natural history of maternal immunization against foetal platelet alloantigens. Transfusion Medicine (Oxford, England), 14, 399-408.
85. Pacheco, L.D., Berkowitz, R.L., Moise, Jr, K.J., Bussel, J.B., McFarland, J.G. & Saade, G.R. (2011) Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and Gynecology, 118, 1157-1163.
86. Peitsidis, P., Datta, T., Pafilis, I., Otomewo, O., Tuddenham, E.G. & Kadir, R.A. (2010) Bernard Soulier syndrome in pregnancy: a systematic review. Haemophilia, 16, 584-591.
87. Peng, T.C., Kickler, T.S., Bell, W.R. & Haller, E. (1991) Obstetric complications in a patient with Bernard-Soulier syndrome. American Journal of Obstetrics and Gynecology, 165, 425-426.
88. Peterson, J.A., McFarland, J.G., Curtis, B.R. & Aster, R.H. (2013a) Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. British Journal of Haematology, 161, 3-14.
89. Peterson, J.A., Kanack, A., Nayak, D., Bougie, D.W., McFarland, J.G., Curtis, B.R. & Aster, R.H. (2013b) Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy. Transfusion, 53, 1309-1318.
90. Pilgrim, H., Lloyd-Jones, M. & Rees, A. (2009) Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technology Assessment, 13, iii, ix-xi, 1-103.
91. Rayment, R., Kooij, T.W., Zhang, W., Siebold, C., Murphy, M.F., Allen, D., Willcox, N. & Roberts, D.J. (2009) Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. Journal of Immunology, 183, 677-686.
92. Roopenian, D.C. & Akilesh, S. (2007) FcRn: the neonatal Fc receptor comes of age. Nature Reviews Immunology, 7, 715-725.
93. Scheffer, P.G., Ait Soussan, A., Verhagen, O.J., Page-Christiaens, G.C., Oepkes, D., de Haas, M. & van der Schoot, C.E. (2011) Noninvasive fetal genotyping of human platelet antigen-1a. BJOG, 118, 1392-1395.
94. Sebring, E.S. & Polesky, H.F. (1990) Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion, 30, 344-357.
95. Shade, K.-T.C. & Anthony, R.M. (2013) Antibody glycosylation and inflammationAntibodies, 2, 392-414.
96. Shields, R.L., Lai, J., Keck, R., O'Connell, L.Y., Hong, K., Meng, Y.G., Weikert, S.H. & Presta, L.G. (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. Journal of Biological Chemistry, 277, 26733-26740.
97. Shulman, N.R., Aster, R.H., Pearson, H.A. & Hiller, M.C. (1962) Immunoreactions involving platelet. VI. Reactions of maternal isoantibodies responsible for neonatal purpura. Differentiation of a second platelet antigen system. Journal of Clinical Investigation, 41, 1059-1069.
98. Simister, N.E. & Story, C.M. (1997) Human placental Fc receptors and the transmission of antibodies from mother to fetus. Journal of Reproductive Immunology, 37, 1-23.
99. Socher, I., Andrei-Selmer, C., Bein, G., Kroll, H. & Santoso, S. (2009) Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion, 49, 943-952.
100. Solomonia, N., Playforth, K. & Reynolds, E.W. (2012) Fetal-maternal hemorrhage: a case and literature review. AJP Reports, 2, 7-14.
101. Stucki, M., Moudry, R., Kempf, C., Omar, A., Schlegel, A. & Lerch, P.G. (1997) Characterisation of a chromatographically produced anti-D immunoglobulin product. Journal of Chromatography B: Biomedical Sciences and Applications, 700, 241-248.
102. Sullivan, M.J., Peterson, J., McFarland, J.G., Bougie, D., Aster, R.H. & Curtis, B.R. (2015) A new low-frequency alloantigen (Kha) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia. Transfusion, 55, 1584-1585.
103. Tiller, H., Killie, M.K., Chen, P., Eksteen, M., Husebekk, A., Skogen, B., Kjeldsen-Kragh, J. & Ni, H. (2012) Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion, 52, 1446-1457.
104. Turner, M.L., Bessos, H., Fagge, T., Harkness, M., Rentoul, F., Seymour, J., Wilson, D., Gray, I., Ahya, R., Cairns, J. & Urbaniak, S. (2005) Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion, 45, 1945-1956.
105. Van den Hof, M.C. & Nicolaides, K.H. (1990) Platelet count in normal, small, and anemic fetuses. American Journal of Obstetrics and Gynecology, 162, 735-739.
106. Vanderpuye, O.A., Labarrere, C.A. & McIntyre, J.A. (1991) A vitronectin-receptor-related molecule in human placental brush border membranes. The Biochem Journal, 280, 9-17.
107. Weiss, E.J., Goldschmidt-Clermont, P.J., Grigoryev, D., Jin, Y., Kickler, T.S. & Bray, P.F. (1995) A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2. Tissue Antigens, 46, 374-381.
108. Westman, P., Hashemi-Tavoularis, S., Blanchette, V., Kekomaki, S., Laes, M., Porcelijn, L. & Kekomaki, R. (1997) Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489). Tissue Antigens, 50, 113-118.
109. Williamson, L.M., Hackett, G., Rennie, J., Palmer, C.R., Maciver, C., Hadfield, R., Hughes, D., Jobson, S. & Ouwehand, W.H. (1998) The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood, 92, 2280-2287.
110. Yougbare, I., Lang, S., Yang, H., Chen, P., Zhao, X., Tai, W.S., Zdravic, D., Vadasz, B., Li, C., Piran, S., Marshall, A., Zhu, G., Tiller, H., Killie, M.K., Boyd, S., Leong-Poi, H., Wen, X.Y., Skogen, B., Adamson, S.L., Freedman, J. & Ni, H. (2015) Maternal anti-platelet beta3 integrins impair angiogenesis and cause intracranial hemorrhage. Journal of Clinical Investigation, 125, 1545-1556.
111. Yu, H., Stowell, S.R., Bernardo, L., Hendrickson, J.E., Zimring, J.C., Amash, A., Uchikawa, M. & Lazarus, A.H. (2014) Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model. Journal of Immunology, 193, 2902-2910.